Experts describe the future of medical sensors as promising

Speakers included Bruce Hellman of uMotif Digital Health, Matthew Heasley from GlaxoSmithKline, Paul Gershlick and Naomi Pryde of Matthew Arnold & Baldwin and Timothy d’Estrube from Accenture Analytics Health & Public Services.

Four workshops were held at the conference, titled ‘The Future of Sensors - A Real Commercial Perspective’, ‘Sensors that are Operational in the Pharmaceutical Arena’, ‘The True Cost of Data Collection’, and ‘Devising Business Value from Analytics’. These workshops allowed attendees to utilise the knowledge which the earlier presentations provided them with.

A panel debate provided the opportunity to further explore issues such as the utilisation of sensors by pharmaceutical corporations, achieving clinical acceptance, and concerns with remote monitoring, specifically given the increasing availability of low cost off-the-shelf sensors. James Weatherall of AstraZeneca and Richard Bailey from EE were among the panellists.

Bruce Hellman, CEO and Co-founder, uMotif Digital Health, commented: “This event added real value, drawing on experience from the healthcare sector but also looking at how we can learn lessons from other industries to address the importance of data-led strategies and the ethical issues linked with this approach. The agenda delivered valuable information to help accelerate our collective learning and knowledge.”

“The workshops provided a stimulating and thought-provoking environment to challenge some of the ideas raised by the speakers. It was an excellent forum for networking and pushing technological boundaries with like-minded people,” said Timothy d’Estrube, Accenture.

Soraya Jones, Chief Executive, CW, said: “This event is always very popular and a great reflection of the strong relationship we have with One Nucleus.”

“Drawing on the resources of both our organisations we are able to provide a vibrant arena for learning, discussion, debate and networking,” added Harriet Fear, CEO, One Nucleus.